Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ligand Pharm (LGND)

Ligand Pharm (LGND)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,056,609
  • Shares Outstanding, K 19,011
  • Annual Sales, $ 251,450 K
  • Annual Income, $ 143,320 K
  • 60-Month Beta 1.28
  • Price/Sales 8.05
  • Price/Cash Flow 11.36
  • Price/Book 2.04

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.40
  • Number of Estimates 1
  • High Estimate 0.40
  • Low Estimate 0.40
  • Prior Year 1.35
  • Growth Rate Est. (year over year) -70.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
94.18 +14.87%
on 10/02/19
109.75 -1.43%
on 10/17/19
+9.21 (+9.31%)
since 09/17/19
3-Month
84.45 +28.10%
on 09/10/19
116.50 -7.14%
on 07/19/19
-4.22 (-3.75%)
since 07/17/19
52-Week
84.45 +28.10%
on 09/10/19
209.00 -48.24%
on 10/18/18
-94.83 (-46.71%)
since 10/17/18

Most Recent Stories

More News
Watch for Ligand Pharm to Potentially Pullback After Gaining 3.57% Yesterday

Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $106.77 to a high of $108.95. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of...

LGND : 108.18 (+1.60%)
Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) ("Ligand" or "the Company") announces the appointment of Sarah Boyce to the Company's Board of Directors, effective today. Ms. Boyce currently serves...

LGND : 108.18 (+1.60%)
Look for Shares of Ligand Pharm to Potentially Pullback after Yesterday's 3.02% Rise

Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $101.80 to a high of $105.15. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of...

LGND : 108.18 (+1.60%)
ImmunoPrecise Strengthens Board of Directors with Antibody Business Leader, Brian Lundstrom

IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTC QB: IPATF) a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, today announced...

IPATF : 0.3689 (+2.44%)
NVO : 52.68 (+0.75%)
IPA.VN : 0.490 (+4.26%)
LGND : 108.18 (+1.60%)
Sermonix Doses First Patient in Phase 2 Clinical Trial of Lasofoxifene for Targeted Precision Medicine Treatment of Women With ESR1 Mutations in Metastatic Breast Cancer

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female-specific oncology products in the precision medicine metastatic breast cancer arena, today...

LGND : 108.18 (+1.60%)
Ligand Pharm is Among the Companies in the Biotechnology Industry with the Best Relative Performance (LGND , CCXI , ALXN , VNDA , UTHR )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

ALXN : 99.99 (+0.48%)
CCXI : 7.99 (+4.44%)
LGND : 108.18 (+1.60%)
Watch for Ligand Pharm to Potentially Pullback After Gaining 4.35% Yesterday

Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $96.92 to a high of $104.21. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high of...

LGND : 108.18 (+1.60%)
Ligand (LGND) Surges: Stock Moves 6.3% Higher

Ligand (LGND) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

LGND : 108.18 (+1.60%)
ACOR : 2.58 (+1.18%)
Look for Shares of Ligand Pharm to Potentially Pullback after Yesterday's 8.39% Rise

Ligand Pharm (NASDAQ:LGND) traded in a range yesterday that spanned from a low of $93.36 to a high of $99.50. Yesterday, the shares gained 8.4%, which took the trading range above the 3-day high of $92.19...

LGND : 108.18 (+1.60%)
Shares of LGND Down 21.2% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Ligand Pharm (NASDAQ:LGND) on May 10th, 2019 at $116.57. In approximately 4 months, Ligand Pharm has returned 21.25% as of today's recent price of $91.80.

LGND : 108.18 (+1.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade LGND with:

Business Summary

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases....

See More

Key Turning Points

2nd Resistance Point 111.63
1st Resistance Point 109.91
Last Price 108.18
1st Support Level 106.30
2nd Support Level 104.41

See More

52-Week High 209.00
Fibonacci 61.8% 161.42
Fibonacci 50% 146.73
Fibonacci 38.2% 132.03
Last Price 108.18
52-Week Low 84.45

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar